SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.375+1.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote (177)11/2/1997 11:36:00 AM
From: Haolin Ni   of 645
 
Hi, Don,

You are right that trading AVIR takes a lot of guts and luck but fundermentally, AVIR has no earning to support it and its products s are non-big deals if you read my posts in July. I am very sorry for those who brought AVIR around $30.

I just could not understand people using long term investments to comfort themself when reality shows opposite way. I am sure you will see AVIR will drop under $20 in the winter because reality has teching investors lessons that high price (like AVIR) with no earning support could not maintaince overvalued price for a long time although it could go up sometime when market is hot, such as DNA, ZITL, GERN and AVIR but it will not happened again in same stocks. Some new black horse will come out one day. Only those companies have solid earning will have great future. I have long term positions in LGND, INTC and CREAF and belive they are much better than AVIR in long run.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext